2-amino-5-phosphonovalerate has been researched along with Congenital Stiff-Man Syndrome in 1 studies
2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xiong, W | 1 |
| Chen, SR | 1 |
| He, L | 1 |
| Cheng, K | 1 |
| Zhao, YL | 1 |
| Chen, H | 1 |
| Li, DP | 1 |
| Homanics, GE | 1 |
| Peever, J | 1 |
| Rice, KC | 1 |
| Wu, LG | 1 |
| Pan, HL | 1 |
| Zhang, L | 1 |
1 other study available for 2-amino-5-phosphonovalerate and Congenital Stiff-Man Syndrome
| Article | Year |
|---|---|
Presynaptic glycine receptors as a potential therapeutic target for hyperekplexia disease.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Brain Stem; Disease Models, Animal; Excitatory Amino | 2014 |